![]() ![]() Rajiv De Silva, president and CEO of Endo International plc (NASDAQ:ENDP) (TSE:ENL) emphasized that deal will create value for the shareholders of both companies. Endo International says merger aligns with its stragegyĮndo International plc (NASDAQ:ENDP) TSE:ENL) said the merger will create a leading specialty healthcare company with expanded platform for future growth. The options are subject to proration in accordance with terms of the agreement.Īuxilium stockholders may choose one of the three options–100% equity, which equates to 0.488 Endo shares per Auxilium share 100% cash ($33.25 per Auxilium share) or a standard selection of an equal mix of 16.625 in cash and 0.244 Endo shares per Auxilium share. The total amount of the deal includes repayment and assumption of debt.Įndo International plc (NASDAQ:ENDP) (TSE:ENL) said the transaction also include options for Auxilium stockholders including cash and stock, all-stock or all-cash consideration for their stakes. (NASDAQ:AUXL) for $33.25 per share.Īccording to Endo International plc (NASDAQ:ENDP) (TSE:ENL), the per share acquisition price represents a 55% premium to the closing price of Auxilium Pharmaceuticals, Inc. Under the agreement, Endo International plc (NASDAQ:ENDP) (TSE:ENL) will purchase all of the outstanding shares of common stock of Auxilium Pharmaceuticals, Inc. View the latest AUXL stock reddit and Twitter threads at MarketBeat. The company initially offered to buy Auxilium for $28.10 per share of $2.2 billion last month. (NASDAQ:AUXL) for $2.6 billion in cash and stock deal. (Free Video) The 2 Secrets To Finding Small-Cap, Hidden Gem Stock Opportunities To Dramatically Grow Your Portfolio Going Into Q4Įndo International plc (NASDAQ:ENDP) (TSE:ENL) entered a definitive agreement to acquired Auxilium Pharmaceuticals, Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |